Jump to content

Meet the Genedata
Biopharma Community

Genedata Biopharma Partner Symposium in Basel, Switzerland: March 23–24, 2022

The Genedata Biopharma Partner Symposium is a unique interdisciplinary event at the interface between biopharma R&D and IT. Presentations and discussions will focus on innovative applications and new industry requirements, such as novel molecular formats (e.g., multispecifics, TCRs, and CARs), MS-based multi-attribute methods (MAM), NGS, molecular-based patient profiling, and increasing automation and standardization in biopharmaceutical R&D.

Leading biopharma companies will show how groups have set up, operate, and use Genedata solutions to transform their biotherapeutics research & development and how this results in increased efficiency and throughput. The symposium brings together people working in all areas of biopharma:

  • Discovery—Screening, selection, engineering, and validation
  • Development—Characterization, optimization, and cell-line engineering
  • Production—Bioprocessing, biosafety, and QC
  • Translational Science—Patient profiling and integrative (pre-)clinical research
  • IT—Infrastructure, networking, and integration

Participants can also take part in targeted break-out sessions, discuss product development roadmaps, and join poster and demo sessions to discover how the Genedata Biopharma Platform is streamlining processes and increasing efficiency throughout biopharmaceutical research, development, and production.

In addition to the scientific program, there will be an evening social networking event and dinner.

Agenda 2022

Day 1 – Wednesday, March 23, 2022
Plenary Session
8:30–9:00Registration & Welcome Coffee
Hyperion Hotel 3rd Floor, Messeplatz 12, Basel, Switzerland
9:00–9:10Opening Remarks
Jana Hersch, Ph.D., Scientific Consultant, Genedata, Basel, Switzerland
9:10–9:30 Challenges in Digitalizing Biopharma R&D
Othmar Pfannes, Ph.D., CEO, Genedata, Basel, Switzerland
9:30–10:00Biologics Discovery at Novartis – Synergies Within and Beyond the Biopharma Platform
Markus Kroemer, Ph.D., Associate Director Data Science, Novartis, Basel, Switzerland
Björn Hüber, Team Leader Data Management, Novartis – NIBR Biologics Center, Basel, Switzerland
10:00–10:30AstraZeneca’s 10 Years of Partnership with Genedata – Innovation, Efficiency, Reliability
Jonathan Wingfield, Ph.D., Principal Scientist, AstraZeneca, Cambridge, UK
Break-out Sessions
Biologics Discovery
Discovery Screening
Mass-Spec Analytics
11:00–11:30Enabling Discovery – Enriching Data Analysis for Biologics at Merck 
Sameh Eid, Ph.D., Principal Scientist, Research Informatics, Merck Healthcare KGaA, Darmstadt, Germany
Implementation of Genedata Screener for Drug Discovery at Lundbeck
Alexander Cahlin, Research Assistant, Lundbeck, Valby, Denmark
From MS-Based Characterization to Automated Data Treatment for ADCs and Oligonucleotides
Anthony Ehkirch, Ph.D., Principal Scientist, Novartis, Basel, Switzerland
11:30–12:00Janssen's High-Throughput Biopharma R&D in the Digital Age

Kimberly Munsell, Senior CSV and Compliance Manager, Janssen, Spring House, PA, USA

Digitalization of R&D at Roche – Challenges, Progress, and Outlook
Romel Bobby, Ph.D., Senior Scientist, Roche, Basel, Switzerland
Anastasios Moresis, Ph.D., Senior Scientist, Roche, Basel, Switzerland
High-Throughput Protein Analysis and Reporting in Industrial Biotechnology
Anders Giessing, Ph.D., Senior Scientist, Novozymes, Bagsvaerd, Denmark
12:00–13:30 Lunch
13:30–14:00Pfizer’s New mRNA Workflows for Vaccines and Therapeutics 
Joel Bard, Ph.D., Associate Research Fellow, BioMedicine Design, Pfizer, Cambridge, MA, USA
Application of High Throughput Cellular Thermal Shift Assays (HT-CETSA) in Early Drug Discovery
Felix Baerenz, Ph.D., Lab Head, In Vitro Biology, Sanofi, Frankfurt, Germany
RP-MAM and HILIC-MAM – A Combined Approach for Highly Glycosylated Fusion Protein
Melanie Jakobczyk, Associate Scientist, Biotech Process Sciences, Merck Healthcare, Corsier-sur-Vevey, Switzerland
14:00–14:30Analytical Workflow Integration in Genedata Biologics
Samuel Cheng, Ph.D., IS Lead Business Consultant, IT RDM Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
High-Throughput Covalent Fragment Screening with MALDI Mass Spectrometry
Don Nguyen, Ph.D., High Throughput Mass Spectrometrist, Bioassay Automation, Discovery Pharmacology, Merck Healthcare KGaA, Darmstadt, Germany
HCP Analysis of Scale Down Model Processes
William Burkitt, Ph.D., Associate Director, UCB, Slough, UK
14:30–15:00Genedata Biologics at Takeda – Adoption and Building Tools for Data Upload
Prashanth Vishwanath, Ph.D., Associate Director, Global Biologics, Takeda, Cambridge, MA, USA
A Hitchhiker’s Guide to the Biophysics Galaxy – Positioning SPR on the Drug Discovery Map
Christine Genick, Ph.D., Principal Scientist II, Lab Head, Novartis, Basel, Switzerland
Open Discussion
The Future of Mass Spectrometry in the Biopharma Industry
Plenary Session
15:10–15:40Utilizing Translational Data Science to Improve Drug Development and Treatment of Patients
Sriram Sridhar, Ph.D, Director, Translational Data Science, Genmab, Princeton, NJ, USA
16:00–18:00Demo & Poster Session 
Meet the Experts – Check out our demos and view posters. Demos are approximately 5–10 minutes and will be repeated on demand throughout the session
19:30–21:30Group Dinner
Day 2 – Thursday, March 24, 2022
Plenary Session
8:30–9:00Welcome Coffee
9:00–9:15Opening Remarks
Jana Hersch, Ph.D., Scientific Consultant, Genedata, Basel, Switzerland
9:15–9:45Sharing Experiences with the Implementation of Genedata BioPharma at Genmab
Rik Rademaker, Ph.D., Director Cell and Molecular Sciences, Genmab, Utrecht, The Netherlands
Break-out Sessions
Biologics Discovery
Discovery Screening
Bioprocess Development
NGS-Driven Biosafety
9:45–10:15The Evolution of Novartis' Biologics Platform – Technical Developments
Desmond Fox, NX Business Analyst, Novartis – NIBR Biologics Center, Basel, Switzerland
Drazen Nadoveza, Ph.D., Senior Principal Software Engineer, Novartis – NIBR Biologics Center, Basel, Switzerland
Implementation of Genedata Screener at Servier
Anne-Laure Ong, Screening Team Leader, Servier, Croissy, France
NGS-Based Methods for the Characterization of Gene Knockouts
Rico Uhler, Ph.D., Group Manager Automation and Data Management, Octapharma, Heidelberg, Germany
10:45–11:15Genedata Biologics at Charles River – Supporting End-to-End Biologics Discovery
Maurice Brozzo, Ph.D., European Antibody Discovery Business Development Manager, Charles River Laboratories, Zurich, Switzerland
Evotec’s RT-qPCR Data Analysis Workflow for Accelerated RNA-Targeted Drug Discovery
Romain Chassefeyre, Ph.D., Project and Team Lead, Evotec, Toulouse, France
Xavier Marechal, Ph.D., Project and Team Lead, Evotec, Toulouse, France
Data View Customization and Report Automation with Genedata Bioprocess
Markus Sanna, Manager Digital Data Excellence and IT Services, Sartorius Stedim Cellca GmbH, Ulm, Germany
Validation Data to Support NGS Purity Testing of Veterinary Master Seeds
Blandine de Saint-Vis, Ph.D., Global MSAT Bio-Analytics – Senior Scientist, Boehringer Ingelheim Animal Health, Saint-Priest, France
11:15–11:45Genedata Biologics – Benchling ELN Integration at Agenus 
Andreas Arnell, Laboratory Informatics Manager, Agenus, Cambridge, UK
AI at Your Fingertips – Automation of High Content Screening Analysis with Genedata Imagence 5.0
Cameron Scott, Scientific Account Manager, Genedata, Basel, Switzerland
Genedata in AgTech – From Clone Pool to Food Protection
Dominique Vlieghe, Ph.D., Data and Information Manager, Biotalys, Ghent, Belgium
A Newly Identified Small RNA Regulates NGNA Sialylation in CHO Cells
Moritz Schmidt, Ph.D., Head of Laboratory Molecular Biology, Boehringer-Ingelheim, Ulm, Germany
Plenary Session
13:15–13:45Genedata Biologics-Supported Workflows for HT Screening of Multi-Specifics: Recent Advances and Future Perspectives
Dilyana Dimova, Ph.D., Senior Data Scientist, Sanofi, Frankfurt, Germany
13:45–14:15Genedata Current and Future Solutions for Automation Laboratories 
Sascha Fischer, Business Development Automation, Genedata, Basel, Switzerland
14:15–14:45Path to Precision Medicine – Connecting People and Data
Tamas Rujan, Head of Genedata Profiler, Business, Basel, Switzerland
Marc Flesch, Ph.D., Head of Genedata Profiler, Product, Munich, Germany
14:45–15:00Closing Remarks
Othmar Pfannes, Ph.D., CEO, Genedata, Basel, Switzerland
15:00–15:30Post Symposium Open Discussion & Farewell Coffee
 End of Symposium

Previous Genedata symposia have included customer presentations from partners including